Prednisolone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia
Conditions:   Esophageal Neoplasms;   Esophagus Stenosis Intervention:   Drug: Oral prednisolone (30mg/day) for 28 days Sponsor:   E-DA Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2023 Category: Research Source Type: clinical trials

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
DiscussionThis experimental medicine study provides a unique opportunity to gain detailed insights into the immunological mechanisms of belimumab-rituximab sequential therapy across multiple body compartments in the setting of AAV.Trial registrationClinicalTrials.gov NCT03967925. Registered on May 30, 2019. (Source: Trials)
Source: Trials - March 11, 2023 Category: Research Source Type: clinical trials